This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2e5e
From Proteopedia
(Difference between revisions)
(New page: 200px<br /><applet load="2e5e" size="350" color="white" frame="true" align="right" spinBox="true" caption="2e5e" /> '''Solution Structure of Variable-type Domain o...) |
|||
| (14 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | [[Image:2e5e.jpg|left|200px]]<br /><applet load="2e5e" size="350" color="white" frame="true" align="right" spinBox="true" | ||
| - | caption="2e5e" /> | ||
| - | '''Solution Structure of Variable-type Domain of Human Receptor for Advanced Glycation Endproducts'''<br /> | ||
| - | == | + | ==Solution Structure of Variable-type Domain of Human Receptor for Advanced Glycation Endproducts== |
| - | + | <StructureSection load='2e5e' size='340' side='right'caption='[[2e5e]], [[NMR_Ensembles_of_Models | 15 NMR models]]' scene=''> | |
| - | [[Category: | + | == Structural highlights == |
| - | [[Category: | + | <table><tr><td colspan='2'>[[2e5e]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2E5E OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2E5E FirstGlance]. <br> |
| - | [[Category: Kobayashi, Y | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2e5e FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2e5e OCA], [https://pdbe.org/2e5e PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2e5e RCSB], [https://www.ebi.ac.uk/pdbsum/2e5e PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2e5e ProSAT]</span></td></tr> |
| - | [[Category: Matsumoto, S | + | </table> |
| - | [[Category: Ohkubo, T | + | == Function == |
| - | [[Category: Yamamoto, H | + | [[https://www.uniprot.org/uniprot/RAGE_HUMAN RAGE_HUMAN]] Mediates interactions of advanced glycosylation end products (AGE). These are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. Acts as a mediator of both acute and chronic vascular inflammation in conditions such as atherosclerosis and in particular as a complication of diabetes. AGE/RAGE signaling plays an important role in regulating the production/expression of TNF-alpha, oxidative stress, and endothelial dysfunction in type 2 diabetes. Interaction with S100A12 on endothelium, mononuclear phagocytes, and lymphocytes triggers cellular activation, with generation of key proinflammatory mediators. Interaction with S100B after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling (By similarity). Receptor for amyloid beta peptide. Contributes to the translocation of amyloid-beta peptide (ABPP) across the cell membrane from the extracellular to the intracellular space in cortical neurons. ABPP-initiated RAGE signaling, especially stimulation of p38 mitogen-activated protein kinase (MAPK), has the capacity to drive a transport system delivering ABPP as a complex with RAGE to the intraneuronal space.<ref>PMID:19906677</ref> |
| - | [[Category: Yasumatsu, I | + | == Evolutionary Conservation == |
| - | [[Category: Yoshida, T | + | [[Image:Consurf_key_small.gif|200px|right]] |
| - | [[Category: | + | Check<jmol> |
| - | [[Category: | + | <jmolCheckbox> |
| - | + | <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/e5/2e5e_consurf.spt"</scriptWhenChecked> | |
| - | + | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | |
| + | <text>to colour the structure by Evolutionary Conservation</text> | ||
| + | </jmolCheckbox> | ||
| + | </jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=2e5e ConSurf]. | ||
| + | <div style="clear:both"></div> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Human]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Kobayashi, Y]] | ||
| + | [[Category: Matsumoto, S]] | ||
| + | [[Category: Ohkubo, T]] | ||
| + | [[Category: Yamamoto, H]] | ||
| + | [[Category: Yasumatsu, I]] | ||
| + | [[Category: Yoshida, T]] | ||
| + | [[Category: Signaling protein]] | ||
| + | [[Category: Variable-type immunoglobulin-like fold]] | ||
Current revision
Solution Structure of Variable-type Domain of Human Receptor for Advanced Glycation Endproducts
| |||||||||||

